Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now full pipeline small index

Mood Disorder: full-pipeline trial registry

2 of 8 indexed Mood Disorder trials are currently recruiting.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

8 US clinical trials · 2 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Mood Disorder: 8 US clinical trials tracked, 2 recruiting.

Mood Disorder is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Mental Health (NIMH), running 6 of these trials.

Enrollment posture brief

Registry condition mood-disorder

OPEN 2 | RECR 25% | LATE 1 | EARLY 1 | RANK #2176 | SPON 6

Nearest open-share peer: Abdominal Pain (25% recruiting · 20 trials)

Activity, Motor75%Achalasia50%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%Mood Disorder (this)25%
Open-enrollment share among volume-matched conditions near Mood Disorder

Mood Disorder lists 2 open slots (25% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Mood Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Mood Disorder is recruiting below its size-band peers.

    2 of 8 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Mood Disorder research.

    National Institute of Mental Health (NIMH) accounts for 6 of 8 trials (75%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Typical Mood Disorder enrolment sits around 1,158 participants.

    Median target enrolment is 1,158 among the 8 trials that report a genuine target (sentinel values excluded). 3 of those (37.5%) plan for fewer than 100 participants.

  4. Mood Disorder research leans observational.

    2 interventional and 6 observational studies make up this index (25% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 41

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 1

Named interventions

Most-linked intervention names on Mood Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Valproic Acid and Depakote ER Drug
1 trials
Hypericum (LI-160) Drug
1 trials
Oxytocin Drug
1 trials
Lithium Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Mood Disorder trials. A trial with sites in several states counts in each.

Maryland 6 trials
Nebraska 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Mood Disorder page

8 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Mood Disorder condition card totals 8 registered trials; most-linked intervention Valproic Acid and Depakote ER; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.